SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Intel Corp. engages in the design, manufacture, and sale of computer products and technologies. It delivers computer, networking, data storage, and communications platforms. The firm operates through the following segments: Client Computing Group (CCG), Data Center and AI (DCAI), Network and Edge (NEX), Mobileye, Accelerated Computing Systems and Graphics (AXG), Intel Foundry Services (IFS), and All Other. The CCG segment consists of platforms designed for notebooks, 2-in-1 systems, desktops, tablets, phones, wireless and wired connectivity products, and mobile communication components. The DCAI segment delivers solutions to cloud service providers and enterprise customers, along with silicon devices for communications service providers and high-performance computing customers. The NEX segment offers computing system solutions from inflexible fixed-function hardware to general-purpose compute, acceleration, and networking devices running cloud native software on programmable hardware. The Mobileye segment develops driving assistance and self-driving solutions. The AXG segment provides products and technologies designed to help customers solve the toughest computational problems. Its products include CPUs for high-performance computing and GPUs targeted for a range of workloads and platforms, from gaming and content creation on client devices to delivering media and gaming in the cloud, and the most demanding high-performance computing and AI workloads on supercomputers. The IFS segment refers to full stack solutions created from the foundry industry ecosystem. The All Other segment represents results from other non-reportable segments and corporate-related charges. The company was founded by Robert Norton Noyce and Gordon Earle Moore on July 18, 1968 and is headquartered in Santa Clara, CA.

Intel Corp.

Intel Corp

Intel is trending following an earnings report that exceeded expectations, sparking optimism about the company's turnaround and future growth prospects in areas like AI. The community is focused on potential short squeezes, new partnerships, and the impact of government investments, while some are wary of overvaluation. Discussions also involve confidence in the CEO's strategy and broader sector dynamics.

Deckers Outdoor Corp. engages in the business of designing, marketing, and distributing footwear, apparel, and accessories developed for both everyday casual lifestyle use and high performance activities. It operates through the following segments: UGG Brand, HOKA Brand, Teva Brand, Sanuk Brand, Other Brands, and Direct-to-Consumer. The UGG Brand segment offers a line of premium footwear, apparel, and accessories. The HOKA Brand segment sells footwear and apparel that offers enhanced cushioning and inherent stability with minimal weight, originally designed for ultra-runners. The Teva Brand segment focuses on the sport sandal and modern outdoor lifestyle category, such as sandals, shoes, and boots. The Sanuk Brand segment originated in Southern California surf culture and has emerged into a lifestyle brand with a presence in the relaxed casual shoe and sandal categories. The Other Brands segment includes the Koolaburra by UGG brand. The Direct-to-Consumer segment consists of retail stores and e-commerce websites. The company was founded by Douglas B. Otto in 1973 and is headquartered in Goleta, CA.

Deckers Outdoor Corp.

Deckers Outdoor (DECK) is trending due to a mix of reactions to earnings, including a beat on estimates coupled with concerns about slowing growth and tariff impacts. The community is debating whether the stock's dip represents a buying opportunity or signals deeper issues with leadership and market sentiment in the retail apparel sector. Discussions also focus on the potential impact of share buybacks and shifting consumer trends in the outdoor and footwear markets.

BigBear.ai Holdings, Inc. engages in data-driven decision dominance and advanced analytics that provide its customers with a competitive advantage in a world driven by data that is growing in terms of volume, variety, and velocity. The firm operationalizes artificial intelligence and machine learning at scale through its end-to-end data analytics platform. It deploys its observe, orient and dominate products to customers throughout the defense, intelligence, and commercial markets. The company was founded in 2020 and is headquartered in McLean, VA.

BigBear.ai Holdings Inc

BigBear.ai (BBAI) is trending as investors discuss the company's potential role in airport security and biometric identity solutions, particularly following news of its technology being deployed at Chicago O'Hare International Airport. Community members are debating the significance of this deployment, with some seeing it as a major catalyst and others wanting to see larger government contracts. Bullish sentiment revolves around BBAI's presence in national security and the potential for further expansion, while bears express concern over dilution and earnings.

Ford Motor Co. engages in the manufacture, distribution, and sale of automobiles. It operates through the following segments: Ford Blue, Ford Model E, Ford Pro, Ford Next, Ford Credit, and Corporate Other. The Ford Blue, Ford Model E, and Ford Pro segment includes the sale of Ford and Lincoln vehicles, service parts, and accessories, together with the associated costs to develop, manufacture, distribute, and service the vehicles, parts, and accessories. The Ford Next segment is involved in the expenses and investments for emerging business initiatives aimed at creating value for Ford in vehicle-adjacent market segments. The Ford Credit segment consists of the Ford Credit business on a consolidated basis, which is primarily vehicle-related financing and leasing activities. The Corporate Other segment refers to corporate governance expenses, past service pension and OPEB income and expense, interest income and gains and losses from cash, cash equivalents, and marketable securities, and foreign exchange derivatives gains, and losses associated with intercompany lending. The company was founded by Henry Ford on June 16, 1903 and is headquartered in Dearborn, MI.

Ford Motor Co.

Ford Motor Co

Ford is trending amid discussions around its Q3 earnings, production adjustments, and the broader EV market. Community sentiment is mixed, with some expressing concerns about lowered profit guidance and the impact of a supplier fire, while others highlight positive sales figures and potential tariff relief. Overall, the stock's movement is tied to both company-specific news and the evolving dynamics of the automotive industry.

Newmont Corp. engages in the exploration and acquisition of gold properties, containing copper, silver, lead, zinc or other metals. It operates through the following geographical segments: Canada, Mexico, Suriname, Argentina, Peru, Australia, Papua New Guinea, Ghana, and U.S. The company was founded by William Boyce Thompson on May 2, 1921 and is headquartered in Denver, CO.

Newmont Corp

Newmont Corp ($NEM) is trending as investors discuss the implications of its recent earnings beat and potential future growth amid rising gold prices. Community members are weighing in on the impact of increased capital spending and debt reduction, as well as the company's exposure to gold's performance. There's also chatter about a potential acquisition and a shift in leadership.

Inhibrx Biosciences, Inc. is a clinical-stage biopharmaceutical company, which includes a pipeline of novel biologic therapeutic candidates, developed using proprietary modular protein engineering platforms. Its clinical pipeline of therapeutic candidates includes INBRX-109 and INBRX-106, both of which utilize multivalent formats where the precise valency can be optimized in a target-centric way to mediate what is believed to be the most appropriate agonist function. The company was founded by Brendan P. Eckelman on January 8, 2024 and is headquartered in La Jolla, CA.

Inhibrx Biosciences Inc.

Inhibrx Inc

Inhibrx is trending due to positive news regarding a potential accelerated approval pathway for its INBRX-101 drug, leading to a significant pre-market surge. The community is actively discussing the validity and impact of this news, with some expecting further gains while others anticipate a pullback. Analysts are weighing in, with raised price targets reflecting optimism about the drug's prospects in treating AATD.

Alphabet, Inc. is a holding company, which engages in software, health care, transportation, and other technologies. It operates through the following segments: Google Services, Google Cloud, and Other Bets. The Google Services segment includes products and services, such as ads, Android, Chrome, devices, Google Maps, Google Play, Search, and YouTube. The Google Cloud segment refers to infrastructure and platform services, collaboration tools, and other services for enterprise customers. The Other Bets segment relates to the sale of healthcare-related services and internet services. The company was founded by Lawrence E. Page and Sergey Mikhaylovich Brin on October 2, 2015 and is headquartered in Mountain View, CA.

Alphabet Inc - Ordinary Shares - Class A

Alphabet Inc Class A

GOOGL is trending due to a cloud deal with Anthropic, giving the AI company access to Google's TPU chips and computing capacity. The community is discussing the potential impact of this deal on AI development and GOOGL's future. Some investors see this as a positive catalyst, while others are concerned about competition and market share.

Cipher Mining, Inc. operates as a Bitcoin mining ecosystem in the United States. The firm is developing a cryptocurrency business. The company was founded in 2021 and is headquartered in New York, NY.

Cipher Mining Inc

Cipher Mining is trending due to Jane Street disclosing a 5% stake, sparking discussions about potential manipulation and future deals, especially given the company's transition to HPC/data centers. The community is debating whether this investment is a positive catalyst or a strategic move to drag the stock down, while also anticipating news regarding a potential deal for 300 MW. Broader sentiment suggests a battle between bulls and bears, with some highlighting the company's strong positioning in the AI infrastructure space.

Lumen Technologies, Inc. is an investment holding company, which engages in the provision of integrated communications to residential and business customers. It operates through the Business and Mass Markets segments. The Business segment provides products and services under four sales channels to enterprise and commercial customers. The Mass Markets segment focuses on consumer and small business customers. The company was founded in 1930 and is headquartered in Monroe, LA.

Lumen Technologies Inc

Lumen Technologies is trending as investors discuss its potential role in AI infrastructure, fueled by a $200M deal with Palantir and upcoming earnings. Community talking points include LUMN being undervalued like PLTR was years ago and its fiber optic network being essential for AI data centers. Some are drawing attention to LUMN's debt, while others suggest the company's strategic shift and AI-driven demand could lead to significant growth.

Teladoc Health, Inc. engages in the provision of telehealthcare services using a technology platform via mobile devices, the Internet, video and phone. It operates through the following segments: Teladoc Health Integrated Care, BetterHelp, and Others. The Teladoc Health Integrated Care segment offers virtual medical services. The BetterHelp segment includes virtual mental health and other wellness services. The company was founded in June 2002 by George Byron Brooks, Michael Gorton, and Gary Wald and is headquartered in New York, NY.

Teladoc Health Inc

Teladoc is trending due to CFO Mala Murthy's departure, sparking community discussion about potential replacements and a shift in company direction. Community members are speculating on a potential rally driven by new leadership and cost-cutting measures. Some investors view the stock as undervalued, while others remain cautious, recalling past performance and leadership concerns.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Stock Market Today: Stocks Sink, Oil Surges After U.S. Imposes New Russian Sanctions

This live blog is refreshed periodically throughout the day with the latest updates from the market.To find the latest Stock Market Today threads, click here.Happy Thursday. This is TheStreet's Stock...

Wellcare Enhances Offering of Affordable, Quality Medicare Advantage and Medicare Prescription Drug Plans in 2026

Wellcare Enhances Offering of Affordable, Quality Medicare Advantage and Medicare Prescription Drug Plans in 2026 Wellcare Enhances Offering of Affordable, Quality Medicare Advantage and Medicare...

Mizuho Securities raised price targets on several large U.S. health insurers following the release of the latest Medicare Advantage star ratings, noting improved visibility into earnings.Analyst Ann Hynes raised her target on CVS Health to $88 from $76, UnitedHealth to $430 from $300, Elevance Health to $420 from $342 and Humana to $345 from $300 and maintained an 'Outperform' rating on all four stocks. The firm also lifted Centene’s target to $40 from $28 with a 'Neutral' rating.Hynes said the target changes were driven by a broader rotation into the healthcare sector after the U.S. government released its 2026 quality ratings for Medicare Advantage and prescription drug plans, which help determine bonus payments to insurers.Barclays also raised its price targets in the group, lifting UnitedHealth’s to $386 from $352 and Elevance Health’s to $395 from $373, both with Overweight ratings. The firm said Medicare remains the most stable business line, Medicaid the most uncertain, and Affordable Care Act exchanges are improving both “fundamentally and from a policy perspective.”CVS Health’s Aetna unit led with over 81% of members in top-rated programs, followed by UnitedHealth at 78%, Elevance at 55%, and Humana at 20%, according to federal data and company disclosures.In all, 64% of Medicare Advantage members with drug coverage are signed up for plans that get four or five stars, Oppenheimer said. The Centers for Medicare &amp; Medicaid Services rates plans on metrics including patient satisfaction, and performance on cancer screenings and management of chronic conditions, among others, according to a Reuters&nbsp;<a class="st-link-external" target="_blank" rel="noopener noreferrer nofollow" href="https://www.reuters.com/legal/litigation/cvs-says-over-81-members-are-high-rated-medicare-advantage-plans-2026-2025-10-09/">report</a>.Four and five-star plans receive bigger government payments that could add up to billions of dollars and have a financial impact in 2027, Oppenheimer said. The research firm added that results broadly matched expectations following company pre-announcements.&nbsp;Elevance showed one of the largest year-over-year gains, with 55% of its membership now in plans rated four stars or higher, up from 40% a year ago, while CVS said 63% of Aetna members are in 4.5-star plans. UnitedHealth said 40% of its members are in 4.5-star plans, and Humana reported 1.2 million members in highly rated offerings.Centene’s Wellcare CEO Michael Carson said the company was encouraged by progress in its star ratings.On Stocktwits, retail sentiment was ‘bullish’ for CVS Health amid ‘normal’ message volume, while sentiment for UnitedHealth, Elevance Health, Humana, and Centene was ‘bearish’ with ‘low’ message volume.So far this year, CVS Health shares are up 77%, while Humana has gained 16%. In contrast, UnitedHealth is down 26%, Elevance Health has slipped 2%, and Centene has dropped 38%.For updates and corrections, email newsroom[at]stocktwits[dot]com.

In this photo illustration, the United States Medicare logo is seen displayed on a smartphone screen. (Photo Illustration by Thomas Fuller/SOPA Images/LightRocket via Getty Images)

CVS, UnitedHealth, Elevance, Humana Gain Price Target Hikes On Wall Street After Medicare Star Ratings Update

Barclays raised targets on UnitedHealth and Elevance, saying Medicare remains the most stable business line, Medicaid the most uncertain, and Affordable Care Act exchanges are improving both fundamentally and from a policy standpoint.

Equity

CVS Health's Aetna Advances Initiative to Curb Hospital Readmissions

CVS company, Aetna, expands its Aetna Clinical Collaboration program to 10 hospitals, aiming to cut readmissions and ease hospital workloads.

Centene Sits at 13.25X P/E: Time to Load Up or Look Away for Now?

CNC's low 13.25X P/E may look attractive, but falling margins, heavy debt and shrinking memberships paint a tougher picture.

Centene Corporation (CNC) announced on Thursday that the company’s business and financial results through August are consistent with its full-year forecast.The company <a target="_blank" rel="noopener noreferrer nofollow" href="https://www.sec.gov/ix?doc=/Archives/edgar/data/0001071739/000107173925000168/cnc-20250911.htm">said</a> in a filing with the U.S. Securities and Exchange Commission that members of its management will discuss the company’s financial results through August at the Deutsche Bank 2025 Healthcare Summit on Thursday. These results, it said, are consistent with the company’s outlook from the July second-quarter earnings call, which stated that it expects full-year adjusted and diluted earnings per share of $1.75.On Stocktwits, retail sentiment around <a href="https://stocktwits.com/symbol/CNC">CNC stock</a> jumped from ‘bullish’ to ‘extremely bullish’ territory over the past 24 hours, while message volume rose from ‘high’ to ‘extremely high’ levels. Shares of the company traded 10% higher at the time of writing.<figure class="image"><img style="aspect-ratio:576/61;" src="https://news.stocktwits-cdn.com/Screenshot_2025_09_11_at_11_29_55_AM_png_418f9b242e.webp" alt="CNC's Sentiment Meter and Message Volume as of 11:30 a.m. ET on Sept. 11, 2025 | Source: Stocktwits" width="576" height="61"><figcaption>CNC's Sentiment Meter and Message Volume as of 11:30 a.m. ET on Sept. 11, 2025 | Source: Stocktwits</figcaption></figure>A Stocktwits user sees the rally as the beginning of a recovery back to $50.<stembedurl>https://stocktwits.com/Hornito/message/628314829</stembedurl>Another user expressed optimism that the stock could reach as high as $70.<stembedurl>https://stocktwits.com/Zado148/message/628307192</stembedurl>“...the Medicaid results for July and August were supportive of the HBR (health benefit ratio) improvement trajectory that we're looking for in the back half of the year,” Centene CEO Sarah London said at the event, according to the transcript provided by Fiscal AI. She also added that the medicare segment continues to be on track for the roughly $700 million of improvement the company talked about in July.After the company’s second-quarter earnings fell below Wall Street estimates, London had <a href="https://stocktwits.com/news-articles/markets/equity/centene-reports-unexpected-q2-loss/chobP3PR5w5">said</a> in July that the company has a clear understanding of the trends that impacted its quarterly performance and is working with urgency to restore its earnings trajectory.CNC stock is down by 43% this year and by about 53% over the past 12 months.Read also:&nbsp;<a href="https://stocktwits.com/news-articles/markets/equity/wolfpack-research-reveals-short-position-in-faraday-future/chwNmHARdvm">Wolfpack Research Reveals Short Position In EV Maker Faraday Future</a>For updates and corrections, email newsroom[at]stocktwits[dot]com.

In this photo illustration a Centene Corporation logo seen displayed on a smartphone with the stock market information of Centene Corporation in the background. (Photo Illustration by Igor Golovniov/SOPA Images/LightRocket via Getty Images)

Centene Stock Rises After Insurer Reaffirms Full-Year Guidance: Retail Sees Stock Rallying Up To $70

The company said that its July and August results are consistent with the company’s outlook from the July second-quarter earnings call.

CVS Health Makes Headway in Stabilizing Aetna: What's Driving It?

CVS makes progress in stabilizing Aetna with leadership, risk management and operational changes.

Humana Wins TVH Assets in Bankruptcy Sale, But Cut Points Drag Shares

HUM scoops up $68M Florida care centers, but star rating hurdles send shares tumbling 12%. Can HUM turn risk into reward?

UnitedHealth Finds Its Stars, Soars 8.6% as Humana Trips on Cut Points

UNH surges 8.6% as it projects stable Medicare Advantage star ratings, easing investor worries over performance.

UnitedHealth Reaffirms 2025 EPS Guidance: Time to Buy or Wait?

UNH reaffirms its 2025 EPS outlook, but mounting costs, legal probes and valuation pressures cloud the path ahead.

Centene Corp. is a healthcare enterprise, which engages in the provision of programs and services to government sponsored healthcare programs. It operates through the following segments: Medicaid, Medicare, Commercial, and Other. The Medicaid segment includes the Temporary Assistance for Needy Families program, Medicaid Expansion programs, the Aged, Blind or Disabled program, the Children's Health Insurance Program, Long-Term Services and Supports, Foster Care, Medicare-Medicaid Plans, which cover beneficiaries who are dually eligible for Medicaid and Medicare, and other state-based programs. The Medicare segment consists of Medicare Advantage, Medicare Supplement, Dual Eligible Special Needs Plans, and Medicare Prescription Drug Plans. The Commercial segment is involved in the Health Insurance Marketplace product along with individual, small group, and large group commercial health insurance products. The Other segment refers to pharmacy operations, Envolve Benefit Options’ vision and dental services, clinical healthcare, behavioral health, the TRICARE program, and corporate management companies. The company was founded in 1984 and is headquartered in St. Louis, MO.

CNC
Centene Corp.

Feed

News

Sentiment

Earnings

Fundamentals

Info

Latest CNC News

CNCCentene Corp.